AMRS~~4.45,BUYYYY,CRAZYY HUGE READ FAST The investment was made by a consortium of high quality institutional and accredited investors and mutual funds with expertise in health care , biotechnology or a consumer orientation consisting of approximately 70% new investors and 30% existing investors. The Company expects to use the proceeds from the offering for general corporate purposes and to repay certain outstanding indebtedness .